4.6 Article

Maternal BMI Associations with Maternal and Cord Blood Vitamin D Levels in a North American Subset of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Participants

Journal

PLOS ONE
Volume 11, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0150221

Keywords

-

Funding

  1. National Institute of Child Health and Human Development [R01-HD34242]
  2. National Institute of Diabetes and Digestive and Kidney Diseases [R01-HD34243]
  3. Friends of Prentice Grants Initiative by Northwestern Memorial Foundation
  4. Eunice Kennedy Shriver National Institute of Child Health AMP
  5. Human Development [K12 HD055884]

Ask authors/readers for more resources

Objective Obesity in pregnancy may be associated with reduced placental transfer of 25-hydroxyvitamin D (25-OHD). The objective of this study was to examine associations between maternal BMI and maternal and cord blood levels of 25-OHD in full term neonates born to a single racial cohort residing at similar latitude. Secondary objectives were to examine associations between maternal glucose tolerance with maternal levels of 25-OHD and the relationship between cord blood 25-OHD levels and neonatal size. Methods This study was conducted among participants of the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study meeting the following criteria: residing at latitudes 41-43 degrees, maternal white race, and gestational age 39-41 weeks. Healthy pregnant women underwent measures of height, weight, and a 75-g fasting oral glucose tolerance test (OGTT) at approximately 28 weeks gestation. Maternal and cord blood sera were analyzed for total 25-OHD by HPLC tandem mass spectrometry. Statistical analyses included ANOVA and linear regression models. Results Maternal and cord blood (N = 360) mean levels (sd) of 25-OHD were 37.2 (11.2) and 23.4 (9.2) ng/ml, respectively, and these levels were significantly different among the 3 field centers (ANOVA p<0.001). Maternal serum 25-OHD was lower by 0.40 ng/ml for BMI higher by 1 kg/m(2) (p<0.001) in an adjusted model. Maternal fasting plasma glucose, insulin sensitivity, and presence of GDM were not associated with maternal serum 25-OHD level when adjusted for maternal BMI. Cord blood 25-OHD was lower by 0.26 ng/ml for maternal BMI higher by 1 kg/m(2) (p<0.004). With adjustment for maternal age, field center, birth season and maternal serum 25-OHD, the association of cord blood 25-OHD with maternal BMI was attenuated. Neither birth weight nor neonatal adiposity was significantly associated with cord blood 25-OHD levels. Conclusion These results suggest that maternal levels of 25-OHD are associated with maternal BMI. The results also suggest that interpretation of neonatal 25-OHD levels may need to incorporate specific maternal factors in addition to season of birth and latitude.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Postpartum uptake of diabetes screening tests in women with gestational diabetes: The PANDORA study

Anna J. Wood, I-Lynn Lee, Elizabeth L. M. Barr, Federica Barzi, Jacqueline A. Boyle, Christine Connors, Elizabeth Moore, Jeremy J. N. Oats, Harold D. McIntyre, Angela Titmuss, Alison Simmonds, Paul Z. Zimmet, Alex D. H. Brown, Sumaria Corpus, Jonathan E. Shaw, Louise J. Maple-Brown

Summary: This study aimed to determine the rates and predictors of postpartum diabetes screening among Aboriginal and/or Torres Strait Islander and non-Indigenous women with gestational diabetes mellitus (GDM). The study found that postpartum screening rates were lower among Aboriginal and/or Torres Strait Islander women compared to non-Indigenous women. Early postpartum screening should be prioritized to detect prediabetes and diabetes among high-risk populations.

DIABETIC MEDICINE (2023)

Article Obstetrics & Gynecology

Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice

Sumaiya Adam, Harold David McIntyre, Kit Ying Tsoi, Anil Kapur, Ronald C. Ma, Stephanie Dias, Pius Okong, Moshe Hod, Liona C. Poon, Graeme N. Smith, Lina Bergman, Esraa Algurjia, Patrick O'Brien, Virna P. Medina, Cynthia Maxwell, Lesley Regan, Mary L. Rosser, Bo Jacobsson, Mark A. Hanson, Sharleen L. O'Reilly, Fionnuala M. McAuliffe

Summary: Gestational diabetes (GDM) affects approximately 17 million pregnancies worldwide. Women with a history of GDM are at a significantly higher risk of developing type 2 diabetes and cardiovascular disease compared to those without prior GDM. Although prevention and delayed progression of GDM to type 2 diabetes is possible, it is not widely practiced. Considering the increasing rates of type 2 diabetes and CVD in women globally, it is crucial to utilize pregnancy as an opportunity for early identification and preventive intervention.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Obstetrics & Gynecology

Management of obesity across women's life course: FIGO Best Practice Advice

Cynthia Maxwell, Rachelle Shirley, Amy C. O'Higgins, Mary L. Rosser, Patrick O'Brien, Moshe Hod, Sharleen L. O'Reilly, Virna P. Medina, Graeme N. Smith, Mark A. Hanson, Sumaiya Adam, Ronald C. Ma, Anil Kapur, Harold David McIntyre, Bo Jacobsson, Liona C. Poon, Lina Bergman, Lesley Regan, Esraa Algurjia, Fionnuala M. McAuliffe

Summary: Obesity is a chronic, progressive, relapsing, and treatable neurobehavioral disease that affects women's health and requires a focus on optimizing health outcomes rather than weight loss. Appropriate and sensitive language, as well as trauma-informed care, is necessary when discussing obesity.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Obstetrics & Gynecology

Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO Best Practice Advice

Liona C. Poon, Long Nguyen-Hoang, Graeme N. Smith, Lina Bergman, Patrick O'Brien, Moshe Hod, Pius Okong, Anil Kapur, Cynthia Maxwell, Harold David McIntyre, Bo Jacobsson, Esraa Algurjia, Mark A. Hanson, Mary L. Rosser, Ronald C. Ma, Sharleen L. O'Reilly, Lesley Regan, Sumaiya Adam, Virna P. Medina, Fionnuala M. McAuliffe

Summary: Hypertensive disorders of pregnancy (HDP) are the leading cause of maternal and perinatal morbidity and mortality, accounting for 16% of maternal deaths in high-income countries and approximately 25% in low- and middle-income countries. HDP increases the risk of future cardiovascular disease. Failure to achieve normal cardiovascular adaptation during pregnancy is associated with the development of HDP. Women with a history of HDP may experience long-term hemodynamic alterations, predisposing them to cardiovascular morbidity and mortality. Therefore, it is crucial to identify underlying cardiovascular risk factors during pregnancy and the postpartum period and develop strategies for lifestyle and therapeutic interventions to reduce the risk of future cardiovascular disease in women with a history of HDP.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Review Obstetrics & Gynecology

Using FIGO Nutrition Checklist counselling in pregnancy: A review to support healthcare professionals

Sarah Louise Killeen, Niamh Donnellan, Sharleen L. O'Reilly, Mark A. Hanson, Mary L. Rosser, Virna P. Medina, Chandni Maria Jacob, Hema Divakar, Moshe Hod, Liona C. Poon, Lina Bergman, Patrick O'Brien, Anil Kapur, Bo Jacobsson, Cynthia Maxwell, Harold David McIntyre, Lesley Regan, Esraa Algurjia, Ronald C. Ma, Sumaiya Adam, Fionnuala M. McAuliffe

Summary: The period before and during pregnancy is crucial for addressing malnutrition and reducing noncommunicable disease risks. The FIGO Nutrition Checklist is a tool designed to address these issues by assessing dietary requirements, body mass index, diet quality, and micronutrients. It generates awareness, identifies risks, and collects information for health-promoting conversations between women and healthcare professionals.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Medicine, Research & Experimental

Total Thyroidectomy and Subsequent Weight Gain in Pediatric Populations

Evan R. Edwards, Inbal Hazkani, Eli Stein, Jami L. Josefson, Jill H. Samis, Jennifer L. Miller, Jeffrey Rastatter

Summary: This study evaluated weight gain in children after thyroidectomy and identified predictors. It found that younger age at thyroidectomy and Hispanic ethnicity were associated with increased body mass index z-scores in the first 2 years post-operation.

LARYNGOSCOPE (2023)

Article Obstetrics & Gynecology

Gestational diabetes mellitus care re-imagined - A cost-minimisation analysis: Cost savings from a tertiary hospital, using a novel, digital-based gestational diabetes management model

Josephine G. Laurie, Shelley A. Wilkinson, Harold D. Mcintyre, Centaine Snoswell

Summary: This study conducted a cost-minimisation analysis comparing a novel, digital-based model for gestational diabetes mellitus (GDM) management with conventional care. The results showed that the intervention group using the digital model achieved a modest health service cost saving of approximately AU$17,441.78 (US$12,158.92) over a 12-month period, while patients saved approximately $566.56 (US$394.96) per patient. Overall, the introduction of the digital-based model resulted in a total saving of $679,872 (US$473,948.82) for the cohort of 1200 women.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2023)

Article Obstetrics & Gynecology

GDM care re-imagined: Maternal and neonatal outcomes following a major model of care change for gestational diabetes mellitus at a large metropolitan hospital

Josephine G. Laurie, Shelley A. Wilkinson, Alison Griffin, Harold D. McIntyre

Summary: This study implemented a novel digital model of care for gestational diabetes mellitus (GDM) and found that it provided similar clinical outcomes to traditional care, while also improving efficiency. The digital model of care has the potential for generalizability to culturally diverse GDM patients and offers important insights for service redesign in the digital era.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2023)

Article Clinical Neurology

Severity and worsening of fatigue among individuals with multiple sclerosis

Amber Salter, Alexander Keenan, Hoa H. Le, Kavita Gandhi, Maria Ait-Tihyaty, Samantha Lancia, Gary R. Cutter, Robert J. Fox, Ruth Ann Marrie

Summary: Fatigue is commonly experienced by multiple sclerosis patients, with a majority reporting worsening of fatigue over time. Factors associated with fatigue worsening include lower income, higher disability, lower initial fatigue level, use of injectable disease-modifying therapies, and increased levels of depression.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2023)

Article Clinical Neurology

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial

Gary Cutter, Richard A. Rudick, Carl de Moor, Carol M. Singh, Elizabeth Fisher, Thijs Koster, Fred D. Lublin, Jerry S. Wolinsky, Henry McFarland, Steven Jacobson, Maria L. Naylor

Summary: This study investigated the changes in serum neurofilament light-chain (sNfL) levels in response to treatment and assessed baseline sNfL as a predictor of relapse in treatment-naive RRMS patients. The results showed that sNfL levels decreased significantly within 6 months and remained low at 36 months in all treatment arms. The combination of lesion activity and sNfL was found to be a stronger predictor of relapse.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2023)

Article Urology & Nephrology

Predialysis Vascular Access Placement and Catheter Use at Hemodialysis Initiation

Michael Allon, Alian Al-Balas, Carlton J. Young, Gary R. Cutter, Timmy Lee

Summary: In CKD patients with an eGFR less than 15 ml/min per 1.73 m2, placement of an AV graft instead of an AV fistula reduces the likelihood of catheter use at the initiation of dialysis.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Urology & Nephrology

Vascular Access-Related Distal Ischemia Requiring Intervention

Michael Allon, Gary R. Cutter, Carlton J. Young

Summary: This study found that access-related distal ischemia requiring intervention was rare. It was more common in women and patients with peripheral vascular disease or coronary artery disease. In some cases, a subsequent vascular access could be placed with a low likelihood of recurrent distal ischemia.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Health Care Sciences & Services

Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis

Marissa Betts, Kyle Fahrbach, Binod Neupane, Mahmoud Slim, Maria Pia Sormani, Gary Cutter, Thomas P. A. Debray, Marvin Rock

Summary: This study evaluates eight approaches for handling overlapping publications in network meta-analyses of real-world evidence (RWE) studies and recommends establishing an a priori hierarchy for selection.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2023)

Article Pediatrics

Leptin and adiposity measures from birth to later childhood: Findings from the Hyperglycemia and Adverse Pregnancy Outcomes Follow-Up Study

Sean DeLacey, Miranda Gurra, Jennifer Arzu, Lynn P. Lowe, William L. Lowe, Denise M. Scholtens, Jami L. Josefson

Summary: The study found a positive association between cord blood leptin and neonatal and childhood adiposity, as well as child leptin levels. This association remained significant even after adjusting for maternal body mass index and glucose levels. Cord blood leptin may serve as a biomarker for future adiposity risk.

PEDIATRIC OBESITY (2023)

Article Pediatrics

One children's hospital planning and development process to adhere to the FDA recommendation that babies and young children undergo thyroid function testing after receiving an injection of iodine-containing contrast media for medical imaging

Dianna M. E. Bardo, Jill H. Samis, Jami L. Josefson, Marcelo R. Malakooti, Paul Tannous, Jeremy L. Fox, Jennifer Elhadary, Amanda Eichstaedt, Kenneth Gray, Agata Nytko, Cynthia K. Rigsby

Summary: This article discusses the FDA's guidelines on thyroid function testing in babies and young children after receiving iodinated contrast media for medical imaging exams. It also describes a hospital's response and implementation strategy to the FDA guidance statement. The hospital tracks and monitors thyroid function in patients under 3 months of age who undergo relevant exams, and has implemented a clinical care guideline.

PEDIATRIC RADIOLOGY (2023)

No Data Available